Elevance Health Inc
NYSE:ELV

  • LAST PRICE
    417.8600
  • TODAY'S CHANGE (%)
    3.8500 (0.9299%)
  • Bid / Lots
    411.8800/ 1
  • Ask / Lots
    419.7500/ 2
  • Open / Previous Close
    415.0000 / 414.0100
  • Day Range
    413.6214
    419.6100
  • 52 Week Range
    397.9800
    567.2600
  • Volume
    1,845,880

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Managed Health Care Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ELV
Elevance Health Inc
96.0B
15.2x
+12.35%
CI
Cigna Group
88.5B
29.5x
+10.57%
CNC
Centene Corp
32.1B
11.1x
+17.00%
HUM
Humana Inc
31.4B
22.6x
+9.96%
MOH
Molina Healthcare Inc
18.7B
16.8x
+12.22%
ALHC
Alignment Healthcare Inc
2.5B
-17.5x
---
As of 2024-11-04

Company Information

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.

Contact Information

Headquarters
220 Virginia AvenueINDIANAPOLIS, IN, United States 46204
Phone
317-488-6000
Fax
---

Executives

Independent Chairman of the Board
Elizabeth Tallett
President, Chief Executive Officer, Director
Gail Boudreaux
Chief Financial Officer, Executive Vice President
Mark Kaye
Executive Vice President and Chief Legal and Administrative Officer
Blair Todt
Executive Vice President and President, Carelon and CarelonRx
Peter Haytaian

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$96.0B
Revenue (TTM)
$174.0B
Shares Outstanding
231.9M
Dividend Yield
1.56%
Annual Dividend Rate
6.5200 USD
Ex-Dividend Date
12-05-24
Pay Date
12-20-24
Beta
0.85
EPS
$27.44
Book Value
$168.64
P/E Ratio
15.2x
Price/Sales (TTM)
0.6
Price/Cash Flow (TTM)
12.3x
Operating Margin
5.40%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.